This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing therapies in development for HDV with a focus on Eiger's lonafarnib
Ticker(s): EIGRWho's the expert?
Institution: Columbia University
- Director of Hepatology Outreach at NY Presbyterian Hospital, Columbia University Medical Center and former medical director of Adult Liver Transplantation at The Montefiore Medical Center
- Has published multiple manuscripts, book chapters, and abstracts, and has participated in numerous research trials related to the therapy of hepatitis B and C, liver transplantation, and treatment of liver failure.
- Fellow of the American College of Physicians, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
